BDX
BECTON, DICKINSON AND COMPANYNYSEResearch view
Healthcare · Surgical & Medical Instruments & Apparatus · Large-cap · SEC EDGAR FY 2025-09-30
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-09-30SectorHealthcare
Market Cap$50.6B
Enterprise Value$69.0B
Income$1.7B
Sales$21.8B
Book/sh$93.21
Cash/sh$2.85
Dividend TTM—
Payout71%
Employees—
IPO—
Quick Ratio0.73
Current Ratio1.11
Debt/Eq0.76
EPS (ttm)$5.82
EPS this Y-0.7%
EPS past 3/5Y-0.3%
Sales past 3/5Y5.0%
EPS Y/Y TTM-0.7%
Sales Y/Y TTM8.2%
Shs Outstand272.39M
ROA3.0%
ROE6.6%
ROIC5.3%
Gross Margin—
Oper. Margin11.8%
Profit Margin7.7%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$19.1B
2021
$18.9B
2022
$19.4B
2023
$20.2B
2024
$21.8B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $19.1B | $18.9B | $19.4B | $20.2B | $21.8B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $2.3B | $2.3B | $2.1B | $2.4B | $2.6B |
| Net Income | $2.1B | $1.8B | $1.5B | $1.7B | $1.7B |
| Diluted EPS | $6.85 | $5.88 | $4.94 | $5.86 | $5.82 |
| Operating Cash Flow | $4.6B | $2.5B | $3.0B | $3.8B | $3.4B |
| Free Cash Flow | $3.5B | $1.5B | $2.1B | $3.1B | $2.7B |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $760.0M against $3.4B operating cash
COMMUNITY · $BDX0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Surgical & Medical Instruments & Apparatus
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.